Company profile
Veradermics
Raising the standard for pattern hair loss.
- Industry
- Pharmaceutical Manufacturing
- Employees
- 44
- Headquarters
- New Haven, CT
- Founded
- 2019
- LinkedIn followers
- 3,652
- Office locations
- 1
Veradermics company summary
Veradermics is a company in the Pharmaceutical Manufacturing industry, headquartered in New Haven, CT, founded in 2019. On LinkedIn the company has around 44 employees and 3,652 followers. Its listed specialties include Dermatology.
What technology does Veradermics use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Veradermics
Veradermics is a late clinical-stage biopharmaceutical company founded by dermatologists with direct clinical experience in the treatment of pattern hair loss, a chronic condition that affects 50 million men and 30 million women in the US alone. Our team combines dermatology expertise, clinical research leadership, and biotechnology innovation to advance new solutions and help bring clarity, evidence, and reliability to pattern hair loss. Our mission: to set a new standard in pattern hair loss by developing treatments rooted in real evidence. Our lead investigational product has the potential to be the first non-hormonal oral therapeutic for hair regrowth in men and women. Pattern hair loss is the largest aesthetics condition worldwide, with no new approved prescription therapies in nearly 30 years. Learn more at www.veradermics.com
Specialties
Where is Veradermics located?
Veradermics lists 1 location.
Compare companies similar to Veradermics
More companies in Pharmaceutical Manufacturing.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Veradermics veradermics.com | Pharmaceutical Manufacturing | 44 | 2019 | New Haven, CT |
Anacor Pharmaceuticals pfizer.com | Pharmaceutical Manufacturing | 108,102 | - | New York, New York |
Sanofi sanofi.com | Pharmaceutical Manufacturing | 93,352 | - | Paris, France, FR |
GSK gsk.com | Pharmaceutical Manufacturing | 92,179 | - | London, England |
Novartis España novartis.com | Pharmaceutical Manufacturing | 85,373 | - | Basel, Baselstadt |
AstraZeneca astrazeneca.com | Pharmaceutical Manufacturing | 80,667 | - | Cambridge, Cambridgeshire, GB |
Eli Lilly and Company lilly.com | Pharmaceutical Manufacturing | 57,202 | - | Indianapolis, Indiana |
Merck merck.us | Pharmaceutical Manufacturing | 44,794 | - | Rahway, New Jersey |
SUN PHARMA sunpharma.com | Pharmaceutical Manufacturing | 47,764 | 1983 | Mumbai, Maharastra |
Boehringer Ingelheim boehringer-ingelheim.com | Pharmaceutical Manufacturing | 47,150 | - | Ingelheim am Rhein, Rhineland-Palatinate |
Cipla cipla.com | Pharmaceutical Manufacturing | 51,911 | - | Mumbai, Maharashtra |
Frequently asked questions about Veradermics
What does Veradermics do?
Veradermics is a late clinical-stage biopharmaceutical company founded by dermatologists with direct clinical experience in the treatment of pattern hair loss, a chronic condition that affects 50 million men and 30 million women in the US alone. Our team combines dermatology expertise, clinical research leadership, and biotechnology innovation to advance new solutions and help bring clarity, evidence, and reliability to pattern hair loss. Our mission: to set a new standard in pattern hair loss by developing treatments rooted in real evidence. Our lead investigational product has the potential to be the first non-hormonal oral therapeutic for hair regrowth in men and women. Pattern hair loss is the largest aesthetics condition worldwide, with no new approved prescription therapies in nearly 30 years. Learn more at www.veradermics.com
How many employees does Veradermics have?
Veradermics has around 44 employees on LinkedIn.
Where is Veradermics headquartered?
Veradermics is headquartered in New Haven, CT.
When was Veradermics founded?
Veradermics was founded in 2019.
Build a lead list from companies like Veradermics
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.